Steady-state PK of omapatrilat in healthy subjects.

被引:8
|
作者
Delaney, CL [1 ]
Jemal, M [1 ]
Beierle, FA [1 ]
Ferreira, IM [1 ]
Davis, KD [1 ]
Meier, A [1 ]
Ford, NF [1 ]
Uderman, HD [1 ]
Liao, W [1 ]
机构
[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA
关键词
D O I
10.1016/S0009-9236(99)80066-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PI66
引用
收藏
页码:133 / 133
页数:1
相关论文
共 50 条
  • [1] The effect of dofetilide on the steady-state PK and cardiac effects of phenytoin in healthy subjects.
    Vincent, J
    Gardner, M
    Scavone, J
    Ashton, H
    Willavize, S
    Friedman, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV69 - PIV69
  • [2] The effects of phenytoin on the steady-state PK and PD of dofetilide in healthy subjects
    Gardner, MJ
    Ashton, HM
    Willavize, SA
    Friedman, HL
    Vincent, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII42 - PII42
  • [3] Lack of pharmacokinetic interaction between retigabine and phenobarbital at steady-state in healthy subjects.
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P48 - P48
  • [4] EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.
    Cho, H.
    Cho, D.
    Yeo, C.
    Bae, S.
    Shon, J.
    Park, S.
    Kim, E.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S95 - S95
  • [5] Pharmacodynamic effects of multiple doses of omapatrilat in healthy subjects.
    Vesterqvist, O
    Liao, W
    Manning, JA
    Uderman, HD
    Delaney, CL
    Swanson, BN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 132 - 132
  • [6] LINAGLIPTIN DOES NOT ALTER THE STEADY-STATE PHARMACOKINETICS OF ETHINYLESTRADIOL AND LEVONORGESTREL (MICROGYNON®) IN HEALTHY ADULT FEMALE SUBJECTS.
    Friedrich, C.
    Ring, A.
    Port, A.
    Graefe-Mody, U.
    Woerle, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S31 - S31
  • [7] LISINOPRIL STEADY-STATE KINETICS IN HEALTHY-SUBJECTS
    BEERMANN, B
    JUNGGREN, I
    COCCHETTO, D
    CIRILLO, VJ
    GOMEZ, HJ
    HICHENS, M
    TILL, AE
    BOLOGNESE, JA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 471 - 471
  • [8] Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy subjects.
    Liu, P
    Foster, G
    Labadie, R
    Gutierrez, MJ
    Sharma, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P40 - P40
  • [9] Omapatrilat does not affect the steady-state of warfarin.
    Mangold, B
    Gielsdorf, W
    Norton, J
    Liao, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 131 - 131
  • [10] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180